A Step Forward for Long-Acting PCSK9 Inhibition Improvements Without a Breakthrough

被引：1
|
作者：
Santos, Raul D. [1 ,2 ]
Nasir, Khurram [3 ]
Shapiro, Michael D. [4 ]
机构：
[1] Univ Sao Paulo, Hosp Israelita Albert Einstein, Acad Res Org, Sao Paulo, Brazil
[2] Univ Sao Paulo, Heart Inst InCor, Sao Paulo, Brazil
[3] Houston Methodist DeBakey Heart & Vasc Ctr, Dept Cardiol, Div Cardiovasc Prevent & Wellness, Houston, TX USA
[4] Wake Forest Univ, Bowman Gray Sch Med, Ctr Prevent Cardiovasc Dis, Sect Cardiovasc Med, Winston Salem, NC 27157 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 84卷 / 20期
基金：
美国国家卫生研究院;
关键词：
KEY WORDS LDL-C; lipoproteins; mixed hyperlipemia; nonfamilial hypercholesterolemia; PCSK9; recaticimab;
D O I：
10.1016/j.jacc.2024.09.019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2048 / 2050
页数：3
相关论文
共 50 条
  • [41] The evolving landscape of PCSK9 inhibition in cancer
    Oza, Palak P.
    Kashfi, Khosrow
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 949
  • [42] PCSK9 inhibition and type 2 diabetes
    Lotta, Luca A.
    Griffin, Simon J.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (12): : 926 - 927
  • [43] Interindividual and Intraindividual Responses to PCSK9 Inhibition
    Thompson, Paul D.
    JAMA CARDIOLOGY, 2019, 4 (06) : 600 - 600
  • [44] PCSK9 inhibition in children with familial hypercholesterolaemia
    Hegele, Robert A.
    LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (10): : 686 - 688
  • [45] The consequences of PCSK9 inhibition in selected tissues
    Maliglowka, Mateusz
    Buldak, Lukasz
    Okopien, Boguslaw
    Boldys, Aleksandra
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2021, 75 : 385 - 397
  • [46] PCSK9 Inhibition to Reduce Cardiovascular Events
    Dullaart, Robin P. F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (18): : 1790 - 1791
  • [47] PCSK9 inhibition and the global diabetes epidemic
    Mascitelli, Luca
    Goldstein, Mark R.
    DIABETOLOGIA, 2017, 60 (04) : 751 - 752
  • [48] An oral antisense oligonucleotide for PCSK9 inhibition
    Gennemark, Peter
    Walter, Katrin
    Clemmensen, Niclas
    Rekic, Dinko
    Nilsson, Catarina A. M.
    Knochel, Jane
    Holtta, Mikko
    Wernevik, Linda
    Rosengren, Birgitta
    Kakol-Palm, Dorota
    Wang, Yanfeng
    Yu, Rosie Z.
    Geary, Richard S.
    Riney, Stan J.
    Monia, Brett P.
    Isaksson, Rikard
    Jansson-Lofmark, Rasmus
    Rocha, Cristina S. J.
    Linden, Daniel
    Hurt-Camejo, Eva
    Crooke, Rosanne
    Tillman, Lloyd
    Ryden-Bergsten, Tina
    Carlsson, Bjorn
    Andersson, Ulf
    Elebring, Marie
    Tivesten, Anna
    Davies, Nigel
    SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (593)
  • [49] New Chapter in the PCSK9 Book: Oral Inhibition of PCSK9 Binding to the LDL Receptor With a Macrocyclic Peptide
    Landmesser, Ulf
    Makhmudova, Umidakhon
    CIRCULATION, 2023, 148 (02) : 159 - 161
  • [50] The biology of PCSK9 inhibition: some unanswered questions
    Lambert, Gilles
    Diotel, Nicolas
    Tavori, Hagai
    EUROPEAN HEART JOURNAL, 2016, 37 (17) : 1345 - 1347
12345